These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8390762

  • 21. Possible contribution to hepatocarcinogenesis of X transcript of hepatitis B virus in Japanese patients with hepatitis C virus.
    Tamori A, Nishiguchi S, Kubo S, Koh N, Moriyama Y, Fujimoto S, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S, Kuroki T.
    Hepatology; 1999 May; 29(5):1429-34. PubMed ID: 10216126
    [Abstract] [Full Text] [Related]

  • 22. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
    Ma CH, Sun WS, Liu SX, Wang XY, Zhang LN, Cao YL, Han LH.
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
    [Abstract] [Full Text] [Related]

  • 23. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.
    Robinson WS.
    Annu Rev Med; 1994 May; 45():297-323. PubMed ID: 8198385
    [Abstract] [Full Text] [Related]

  • 24. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
    Zhu R, Li BZ, Ling YQ, Zhang HP, Li H, Liu Y, Hu XQ, Zhu HG.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
    [Abstract] [Full Text] [Related]

  • 25. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 26. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Association of p16INK4A hypermethylation with hepatitis B virus X protein expression in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu R, Li BZ, Li H, Ling YQ, Hu XQ, Zhai WR, Zhu HG.
    Pathol Int; 2007 Jun; 57(6):328-36. PubMed ID: 17539963
    [Abstract] [Full Text] [Related]

  • 31. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells.
    Chan DW, Ng IO.
    J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167
    [Abstract] [Full Text] [Related]

  • 32. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx.
    Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Bréchot C.
    Oncogene; 1999 Aug 26; 18(34):4848-59. PubMed ID: 10490818
    [Abstract] [Full Text] [Related]

  • 33. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D.
    Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
    Lee Y, Park US, Choi I, Yoon SK, Park YM, Lee YI.
    Clin Cancer Res; 1998 Jul 01; 4(7):1711-7. PubMed ID: 9676846
    [Abstract] [Full Text] [Related]

  • 36. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma.
    Sze KM, Chu GK, Lee JM, Ng IO.
    Hepatology; 2013 Jan 01; 57(1):131-9. PubMed ID: 22821423
    [Abstract] [Full Text] [Related]

  • 37. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr 01; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 38. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 39. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
    Tabor E.
    Princess Takamatsu Symp; 1995 May 01; 25():151-61. PubMed ID: 8875620
    [Abstract] [Full Text] [Related]

  • 40. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
    Tu H, Gao HF, Ma GH, Liu Y.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1249-52. PubMed ID: 16796883
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.